AMD Zen 2 Release Date, Specs: What Does MSI Has To Say About Motherboard Compatibility Issue? 
‘GTA 6’ Latest News, Update: Online Multiplayer to Feature ‘Burnout’ Style Race? Might Not Be in Development 
'Super Mario Maker 2’ Release Date, Pre-Order Details: Are There Perks to Buying It Early? 
‘World of Warcraft Classic’ Release Date, Latest News, Update: Is a Beta Version Coming Out Soon? 
DJI Phantom 5 Release Date, Latest News, Update: Upcoming Drone to Have 30-40 Mins Flight Time? 
iPhone X Mini 2019: Why Apple Axed the Smartphone’s Development 
'The Last of Us Part II' Latest News, Update: How Mo-Cap Wrap-Up Hints at 2020 Release 
‘The Last of Us Part 2’ Release Date, Latest News: How True is the Slovakian Retailer Leak? 
Torrent 2019: Why Canadians Should Be Wary of Illegally Downloading ‘Game of Thrones’ 
'GTA 6' Latest News, Update: How Former Rockstar Employee Resume Confirms Game’s Development 
Can bacteria help us prevent salt damage to concrete roads and bridges? 
‘Harry Potter: Wizards Unite’ Release Date, Latest News, Update: How the Game is Looking So Far 
Cancer Cure 2019: University of Colorado Research Sparks Hope as AML Patient Marks 2nd Anniversary of Remission 
- News
- Economy
- Central Banks
- Investing
- Research
- Roundups
- Digital Currency
- Insights
- Technical Analysis
- Technology
- Business
- Law
- Health
- Nature
- Fintech
- Science
- Topic
- Opinions
- EconoTimes PRO
- ©Elmin Media . All Rights Reserved.
Automation Takes Over Stem Cell Manufacturing Too, FDA Approves
Stem Cell Illustration.PublicDomainPictures/Pixabay
When discussing stem cell research, most people would likely bring up scientists harvesting stem cells from living tissue. While this is certainly true, there is now a new method that would allow researchers to manufacture stem cells so that they have much more of it to work with. The U.S. Food and Drug Administration (FDA) recently approved the process employed by the Mayo Clinic, which actually automates the process.
In a press release, the Mayo Clinic describes both the process and implications of the FDA approval to stem cell research. Apparently, this allows the researchers to take the bone marrow of a donor and then produce a much higher quantity of stem cells that will then be used to advance research in regenerative medicine.
According to the medical director of Transfusion Medicine and the Human Cell Therapy Laboratory, Abba Zubair, this process is a huge boon for cases where the patient’s own stem cells are not enough to allow for treatment. These cases can often be a problem, mostly because harvesting stem cells is not exactly that easy.
“This may make treatments possible in cases where the patient’s own cells are not viable as therapy,” Dr. Zubair said. “In addition, because the cells can be produced in days instead of months, it may also make treatments available on short notice when they’re needed for acute care.”
As Futurism notes, stem cell research has already proven promising in a variety of treatment cases, addressing everything from arthritis to paralysis. By cranking up production of stem cells via an automated production method, not only will researchers have significantly more batches to work with, patients won’t have to wait for months to be treated.
On a side note, this process also highlights the huge advantages to automating the manufacturing process in the field of research and medicine. In these areas, robots are just taking over, and that might be for the best.
Editor's Picks
April 26 01:30 UTC Released
AUImport Prices*
Actual
-0.5 %
Forecast
Previous
0.5 %
April 26 01:30 UTC Released
AUBudget, Year-To-Date, C$*
Actual
4.5 Bln CAD
Forecast
Previous
4.4 Bln CAD
January 31 00:00 UTC 648108m
ARAnnual Primary Balance*
Actual
Forecast
2016 bln ARS
Previous
Bln AR bln ARS
January 31 00:00 UTC 648108m
ARAnnual Primary Balance*
Actual
Forecast
2016 bln ARS
Previous
Bln AR bln ARS
January 22 19:00 UTC 659928m
ARTrade Balance
Actual
Forecast
Previous
-1541 %
January 31 00:00 UTC 648108m
ARAnnual Primary Balance*
Actual
Forecast
2016 bln ARS
Previous
Bln AR bln ARS
January 22 19:00 UTC 659928m
ARTrade Balance
Actual
Forecast
Previous
-1541 %
January 31 00:00 UTC 648108m
ARAnnual Primary Balance*
Actual
Forecast
2016 bln ARS
Previous
Bln AR bln ARS
January 31 00:00 UTC 648108m
ARAnnual Primary Balance*
Actual
Forecast
2016 bln ARS
Previous
Bln AR bln ARS
January 31 00:00 UTC 648108m
ARAnnual Primary Balance*
Actual
Forecast
2016 bln ARS
Previous
Bln AR bln ARS
